Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53

Cell Death & Disease
Mannu K WaliaCarl R Walkley

Abstract

The loss of p53 function is a central event in the genesis of osteosarcoma (OS). How mutation of p53 enables OS development from osteoblastic lineage cells is poorly understood. We and others have reported a key role for elevated and persistent activation of the cAMP/PKA/Creb1 pathway in maintenance of OS. In view of the osteoblast lineage being the cell of origin of OS, we sought to determine how these pathways interact within the context of the normal osteoblast. Normal osteoblasts (p53 WT) rapidly underwent apoptosis in response to acute elevation of cAMP levels or activity, whereas p53-deficient osteoblasts tolerated this aberrant cAMP/Creb level and activity. Using the p53 activating small-molecule Nutlin-3a and cAMP/Creb1 activator forskolin, we addressed the question of how p53 responds to the activation of cAMP. We observed that p53 acts dominantly to protect cells from excessive cAMP accumulation. We identify a Creb1-Cbp complex that functions together with and interacts with p53. Finally, translating these results we find that a selective small-molecule inhibitor of the Creb1-Cbp interaction demonstrates selective toxicity to OS cells where this pathway is constitutively active. This highlights the cAMP/Creb axis as a...Continue Reading

References

Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·H WernerD LeRoith
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·T MassfelderA F Stewart
Dec 1, 2000·Nature·B VogelsteinA J Levine
Nov 21, 2001·The Journal of Biological Chemistry·William H HoffmanMaureen Murphy
Dec 10, 2003·Oncogene·Jordan S Fridman, Scott W Lowe
Jul 21, 2004·Molecular Cell·Kam Y J ZhangGideon Bollag
Mar 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xinmin ZhangMarc Montminy
Apr 13, 2007·Biochimica Et Biophysica Acta·Krishnaraj RajalingamStefan Albert
May 14, 2008·Neoplasia : an International Journal for Oncology Research·Damian J JunkBernard W Futscher
Jul 28, 2009·The Journal of Biological Chemistry·Andrey S DobroffMenashe Bar-Eli
Jul 6, 2010·Biochemical and Biophysical Research Communications·Jieun SonZang Hee Lee
Aug 11, 2010·Bone·Katherine A Janeway, Carl R Walkley
Aug 11, 2010·The Journal of Clinical Investigation·Sam D MolyneuxRama Khokha
May 1, 2012·Bioinformatics·Xiaoli JiaoRichard A Lempicki
Oct 6, 2012·Clinical Sarcoma Research·Alvin Jm NgCarl R Walkley
Nov 15, 2012·Current Opinion in Oncology·Pierre Hainaut, Amelie Plymoth
Jun 4, 2013·Nature Genetics·Sharon A SavageStephen J Chanock
Apr 8, 2014·Cell Reports·Xiang ChenUNKNOWN St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project
Apr 18, 2014·Nature Reviews. Cancer·Kathryn T BiegingLaura D Attardi
Dec 17, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jennifer A PerryKatherine A Janeway
Jul 15, 2016·Cold Spring Harbor Perspectives in Medicine·Yael Aylon, Moshe Oren
Aug 5, 2017·Cell Death and Differentiation·Natalia ArtigasFrancesc Ventura

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry
ChIP
X-ray
ChIP-seq
immunoprecipitation

Software Mentioned

FlowJo
DAVID
Cell Quest
Modfit Lt
Prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis